tirzepatide category Shifts in body mass index with and associated changes in cardiometabolic risk factors in people with obesity: a post hoc analysis from the SURMOUNT-1 and SURMOUNT-4 trials Prevalence of patients meeting the

Clin Nutr (2017) 36(6):17079.10.1016/j.clnu.2016.09.028 187 LiuRHongJXuXFengQZhangDGuYet alGut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

Oral Supplements: Which Is More Effective for Weight Loss

Reviewing this framework helps clarify what each compound addresses and where redundancy or complementary benefit may occur

In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity.

Zhu H, Wang X, Wallack M, et al